Active Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The National Institutes of Health has issued a Special Notice regarding the ASCENT-IBO initiative, focusing on the clinical evaluation of ibogaine for improving outcomes in opioid use disorder. This notice includes information about a Proposers’ Day event and builds upon previous announcements. Interested parties should review the attached notice for further details.
See attached Special Notice ARPA-H-SN-26-158: Accelerating Safe Clinical Evaluation of Novel Treatments: Ibogaine for Better outcomes in OUD (ASCENT-IBO)
This Special Notice builds upon ARPA-H-SN-26-156 and includes details related to a Proposers’ Day event.
AREA OF INTEREST UNDER PHO ISO: ASCENT-IBO is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.